MOLBIO reports Rs 52.74 cr Q1FY27 profit at 24.63% margin
Interest, depreciation and a 30.52% tax rate reduced the conversion of Rs 100.58 cr operating profit into net profit.
Filed 05 Sep 2026, 18:53 IST · after market close · Molbio Diagnostics Ltd (MOLBIO)
Key takeaways
- Molbio's consolidated operating margin was 24.63%, 4.15 percentage points above the 20.48% median for 113 reporting healthcare peers.
- Consolidated net profit was Rs 52.74 cr after a 30.52% tax rate, with interest and depreciation together weighing on pre-tax earnings.
- The stock fell 2.87% on the first reaction but was up 16.92% after five sessions.
Price around the results
Q1FY27 margin stood above the healthcare peer median
Molbio reported consolidated revenue of Rs 408.38 cr and operating profit of Rs 100.58 cr for Q1FY27, translating into a 24.63% operating margin. That was 4.15 percentage points above the 20.48% median margin among 113 healthcare peers that had reported the quarter.
Interest, depreciation and tax shaped profit conversion
Interest of Rs 10.70 cr and depreciation of Rs 17.07 cr reduced the conversion from operating profit to pre-tax profit of Rs 75.91 cr. Other income was Rs 3.10 cr, while tax of Rs 23.16 cr at a 30.52% rate brought consolidated net profit to Rs 52.74 cr and EPS to Rs 5.21.
Initial market reaction reversed over five sessions
The shares fell 2.87% on the first reaction, with the move against the market at -2.37%. The stock was up 16.92% after five sessions, making the later move materially different from the initial decline; the results were filed after market close on 5 September 2026.
Q1FY27 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹408 cr |
| Other income | ₹3 cr |
| Expenses | ₹308 cr |
| Operating profit | ₹101 cr |
| Operating margin (%) | 24.63% |
| Interest | ₹11 cr |
| Depreciation | ₹17 cr |
| Profit before tax | ₹76 cr |
| Tax | ₹23 cr |
| Net profit | ₹53 cr |
| EPS (₹) | ₹5.21 |
Operating margin of 24.63% compares with a Healthcare sector median of 20.48% across 113 peers that have reported Q1FY27.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -2.87% | -2.37% |
| Next session | -3.71% | — |
| 5 sessions | +16.92% | +20.18% |
| 15 sessions | +8.19% | — |
Volume on the results session was 0.30× its 20-day average.
What to watch
- Whether operating margin holds above 24.63%.
- Whether interest stays below Rs 10.70 cr as profit converts from operating earnings.
- Whether the tax rate remains near 30.52%.